Exact Sciences Corp [EXAS] stock is trading at $45.6, up 1.36%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EXAS shares have gain 11.25% over the last week, with a monthly amount drifted -12.66%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exact Sciences Corp [NASDAQ: EXAS] stock has seen the most recent analyst activity on April 10, 2025, when Mizuho initiated its Outperform rating and assigned the stock a price target of $60. Previously, RBC Capital Mkts started tracking the stock with Sector Perform rating on March 13, 2025, and set its price target to $52. On January 23, 2025, Barclays initiated with a Overweight rating and assigned a price target of $70 on the stock. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $75 on August 28, 2024. Scotiabank initiated its recommendation with a Sector Outperform and recommended $70 as its price target on June 27, 2024. In a note dated January 02, 2024, The Benchmark Company upgraded an Buy rating on this stock but restated the target price of $91.
Exact Sciences Corp [EXAS] stock has fluctuated between $38.81 and $72.83 over the past year. Currently, Wall Street analysts expect the stock to reach $53 within the next 12 months. Exact Sciences Corp [NASDAQ: EXAS] shares were valued at $45.6 at the most recent close of the market. An investor can expect a potential return of 16.23% based on the average EXAS price forecast.
Analyzing the EXAS fundamentals
Exact Sciences Corp [NASDAQ:EXAS] reported sales of 2.94B for the trailing twelve months, which represents a growth of 15.99%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at -0.34%, Pretax Profit Margin comes in at -0.35%, and Net Profit Margin reading is -0.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.38 and Total Capital is -0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 44.84 points at the first support level, and at 44.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.31, and for the 2nd resistance point, it is at 47.02.
Ratios To Look Out For
For context, Exact Sciences Corp’s Current Ratio is 2.89. In addition, the Quick Ratio stands at 2.56 and the Cash Ratio stands at 1.26. Considering the valuation of this stock, the price to sales ratio is 2.94, the price to book ratio is 3.49.
Transactions by insiders
Recent insider trading involved Doyle James Edward, Director, that happened on Aug 13 ’25 when 1485.0 shares were sold. Director, Doyle James Edward completed a deal on Aug 13 ’25 to buy 1485.0 shares. Meanwhile, Former Director Sebelius Kathleen bought 8164.0 shares on Jul 16 ’25.
